Shannon Breen
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
- Oncology 6
- CAR-T cell therapy research 2
- Cytokine Signaling Pathways and Interactions 2
- PARP inhibition in cancer therapy 1
- HER2/EGFR in Cancer Research 1
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Haihong Zhong (7 shared papers)Robert E. Hollingsworth (3 shared papers)Jiaqi Huang (3 shared papers)Christine A. Fazenbaker (3 shared papers)Herren Wu (2 shared papers)Changshou Gao (2 shared papers)Yihong Yao (2 shared papers)Sandra M. Lynch (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (2 papers)Journal of Clinical Investigation (1 paper)mAbs (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Shannon Breen
13 papers receiving 377 citations
Peers
Comparison fields: 5 of 48
- Radiology, Nuclear Medicine and Imaging 118
- Oncology 114
- Hematology 36
- Endocrinology, Diabetes and Metabolism 26
- Cancer Research 19
Countries citing papers authored by Shannon Breen
This map shows the geographic impact of Shannon Breen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Breen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Breen more than expected).
Fields of papers citing papers by Shannon Breen
This network shows the impact of papers produced by Shannon Breen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Breen. The network helps show where Shannon Breen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shannon Breen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 58 | |
| 2 | 2018 | 52 | |
| 3 | 2016 | 43 | |
| 4 | 2017 | 41 | |
| 5 | 2017 | 41 | |
| 6 | 2023 | 39 | |
| 7 | 2016 | 29 | |
| 8 | 2024 | 27 | |
| 9 | 2014 | 21 | |
| 10 | 2017 | 20 | |
| 11 | 2018 | 19 | |
| 12 | 2018 | 15 | |
| 13 | 2012 | 1 |
About Shannon Breen
Shannon Breen is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Organic Chemistry, Endocrinology, Diabetes and Metabolism and Hematology, having authored 13 papers that have together received 406 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers), CAR-T cell therapy research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Breast Cancer Treatment Studies (1 paper), PARP inhibition in cancer therapy (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (118 citations), Oncology (114 citations), Hematology (36 citations), Endocrinology, Diabetes and Metabolism (26 citations) and Cancer Research (19 citations). Shannon Breen has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Haihong Zhong, Robert E. Hollingsworth, Jiaqi Huang, Christine A. Fazenbaker, Herren Wu, Changshou Gao, Yihong Yao, Sandra M. Lynch, Dong Young Kim and Raimund J. Ober. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Journal of Clinical Investigation, mAbs and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.